Short Answer
Medical cannabis has a short list of benefits with strong evidence and a longer list with weak or mixed evidence. The strongest support covers chronic pain in adults, nausea and vomiting from chemotherapy, and muscle spasticity from multiple sclerosis. Two synthetic THC drugs, dronabinol and nabilone, are FDA-approved for chemotherapy-related nausea, and a purified CBD drug is FDA-approved for three severe seizure disorders. Support for anxiety, glaucoma, inflammatory bowel disease, and post-traumatic stress disorder is thin, mixed, or both.
read more
Before You Start
- A qualifying diagnosis from a physician licensed in your state
- A state medical cannabis card or registry identification number
- A current medication list so your prescriber can check for interactions
- A defined goal: pain, sleep, nausea, appetite, or spasticity
The Medical Cannabis Benefits List
Items are ordered from strongest evidence to weakest. "Strong" means multiple controlled studies or a national review reached the same conclusion, not that cannabis replaces standard care.
Best Medical Cannabis Strains for Anxiety: Top Picks and Alternatives
- Chronic pain in adults. This is the best-supported use. A National Academies review found conclusive evidence that cannabis or cannabinoids reduce chronic pain, with the clearest results in neuropathic pain and pain from multiple sclerosis. Most patients use it after standard options fail, not instead of them.
- Chemotherapy-induced nausea and vomiting. Oral dronabinol and nabilone are FDA-approved for nausea and vomiting that standard antiemetics do not control. Benefit is measured as fewer vomiting episodes and better tolerance of treatment cycles.
- Muscle spasticity in multiple sclerosis. The National Academies review found conclusive evidence for spasticity symptom relief. A THC and CBD oral spray is approved in several countries but not in the United States, where patients use state-regulated products off-label.
- Severe childhood epilepsy. A purified CBD oral solution is FDA-approved for seizures tied to Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. It is used alongside other antiseizure drugs, and liver enzymes need monitoring.
- Appetite and weight loss in AIDS-related wasting. Dronabinol carries an FDA indication for anorexia associated with weight loss in AIDS patients. Evidence in cancer-related wasting is weaker.
- Sleep problems tied to pain. Sleep often improves when pain improves, but studies of cannabis as a standalone sleep aid are small and short. Tolerance to the sedating effect can build within days.
- Anxiety and depression. Mixed. Low-dose CBD shows some promise in small trials. THC can trigger or worsen anxiety, panic, and paranoia, especially at high doses.
- Glaucoma. Cannabis lowers eye pressure for about an hour and requires near-constant dosing. Some evidence suggests CBD can raise eye pressure. It is not a substitute for standard treatment.
- Crohn's disease, PTSD, and Tourette syndrome. Insufficient evidence. Reviews describe small samples, inconsistent dosing, and results that other groups could not repeat.
How to Judge a Benefit Claim
Ask three questions about any claim you read: How many people were studied, was there a control group, and did the study measure a real outcome such as pain scores or seizure counts? Reviews that pool many trials carry more weight than a single patient story. A claim that cannabis treats "over 100 conditions" is not a benefit list. It is a marketing line.
medical cannabis dosage guide
Limits and Risks
- Cannabis can cause dependence. Federal health agencies estimate about 3 in 10 users develop cannabis use disorder.
- Regular use in adolescence may affect brain development.
- THC impairs driving and coordination for hours after use.
- Smoked cannabis exposes the lungs to tar and irritants.
- Cannabis can interact with blood thinners, antiseizure drugs, and some antidepressants.
- Medical cannabis is not covered by Medicare, and most commercial insurers do not cover it.
Bottom Line
Build your expectations from the top of this list. Pain, chemo nausea, MS spasticity, and specific pediatric seizure disorders have the evidence. For everything below that, treat cannabis as experimental and talk with your physician before you change any prescription.